BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11056429)

  • 1. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.
    Hani N; Casper C; Groth W; Krieg T; Hunzelmann N
    Eur J Dermatol; 2000; 10(7):548-50. PubMed ID: 11056429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives.
    Chen W; Hsieh FS
    Eur J Dermatol; 2002; 12(5):488-90. PubMed ID: 12370143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
    Severino G; Chillotti C; De Lisa R; Del Zompo M; Ardau R
    Ann Pharmacother; 2005 Jan; 39(1):162-4. PubMed ID: 15546944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome induced by carbamazepine.
    Czajkowski R; Weiss-Rostkowska V; Wankiewicz A; Drewa T; Placek W; Biedka M; Zegarska B
    Acta Pol Pharm; 2007; 64(1):89-92. PubMed ID: 17665856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
    Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation.
    Surovik J; Riddel C; Chon SY
    J Drugs Dermatol; 2010 Aug; 9(8):1010-2. PubMed ID: 20684153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis.
    Primka EJ; Camisa C
    J Am Acad Dermatol; 1997 May; 36(5 Pt 2):815-8. PubMed ID: 9146556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blistering drug reactions].
    Roujeau JC
    Rev Prat; 2000 Jun; 50(12):1320-3. PubMed ID: 10972073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
    Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 and its soluble receptor in selected drug-induced cutaneous reactions.
    Chodorowska G; Czelej D; Niewiedzioł M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):7-13. PubMed ID: 15323158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous ulceration caused by methotrexate.
    Kazlow DW; Federgrun D; Kurtin S; Lebwohl MG
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S197-8. PubMed ID: 12894123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.